Journal of Cancer Research and Therapeutics Close
 

Figure 12: Expression analysis of (a) GMPS, (b) EHMT2, (c) HGF, (d) PDGFRα, and (e) SPRY2 in nontumor, cirrhosis, and hepatocellular carcinoma samples

Figure 12: Expression analysis of (a) GMPS, (b) EHMT2, (c) HGF, (d) PDGFRα, and (e) SPRY2 in nontumor, cirrhosis, and hepatocellular carcinoma samples